கட்டமைப்பு இதயம் உச்சிமாநாடு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from கட்டமைப்பு இதயம் உச்சிமாநாடு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In கட்டமைப்பு இதயம் உச்சிமாநாடு Today - Breaking & Trending Today

Proactive Investors China - The web's leading portal for China stocks - Anteris Technologies achieves breakthrough in ADAPT® products to create consistently thin tissue


2021-07-12
by Proactive Australia
Anteris Technologies Ltd (ASX:AVR) has achieved a breakthrough in manufacturing the tissue used in ADAPT® treated products from bovine pericardium, after developing specialised machinery to create consistently thin tissue through an innovative processing technique.
This process reduces the native pericardia thickness to yield tissue with the desired thickness to make its 3D single-piece aortic valves.
Valve durability studies
Anteris says thinning tissue on-demand is a challenging engineering feat, which is achieved by several custom equipment iterations and parameter adjustments.
Tissue tests demonstrated tensile strength properties equivalent to current ADAPT® treated pericardia.
Valve durability studies proving absolute equivalence between the processed tissue and native (thin) tissue are the confirmatory next step. ....

Anteris Technologies Ltd , Anteris Technologies , Technologies Ltd , Transcatheter Valve Therapies , Structural Heart Summit , Call For Innovation , தொழில்நுட்பங்கள் லிமிடெட் , கட்டமைப்பு இதயம் உச்சிமாநாடு ,

Anteris Technologies Ltd achieves breakthrough in ADAPT® products to create consistently thin tissue


Anteris Technologies achieves breakthrough in ADAPT® products to create consistently thin tissue
The proven benefits of its ADAPT® tissue technology, paired with DurAVR™’s unique 3D single piece aortic valve design, have potential to deliver a functional cure to aortic stenosis patients and provide a much-needed solution to the challenges facing heart surgeons.
Anteris a structural heart company delivering clinically superior and durable solutions through better science and better design.
Anteris Technologies Ltd (ASX:AVR) has achieved a breakthrough in manufacturing the tissue used in ADAPT® treated products from bovine pericardium, after developing specialised machinery to create consistently thin tissue through an innovative processing technique. ....

Transcatheter Valve Therapies , Structural Heart Summit , Call For Innovation , கட்டமைப்பு இதயம் உச்சிமாநாடு ,